Analyst Ratings for Eidos Therapeutics (EIDX)

EIDX Rating Summary

EIDX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on EIDX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $91.75 (-24.9%) * Over Last 12-Mos
Rating Score: 1 / 10   Percentile Rank: 7%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/18/2020 BTIG Thomas Shrader Downgrade Neutral
(Buy)
N/A
(N/A)
81.21
(122.21)
50.49% Details
10/7/2020 Citi
» Updated 12/29/2020
Joel Beatty Downgrade Neutral
(Buy)
129.00
(73.26)
73.51
(122.21)
66.25% Details
Like EIDX Ratings? Also take a look at BBIO

EIDX Ratings News